Friday, April 25, 2014

more scrutiny results from UCLA $10 mil whistleblower settlement story

see LAT: More scrutiny for UCLA's School of Medicine

"The study found that 41 board members at large drug companies held leadership posts at academic medical centers. Their average compensation for serving as a company director was $312,564."
and
"These leaders are wearing two very important hats at the same time," said Gellad, the study's co-author. "There are a lot of benefits from academic medical centers having interactions with industry, but we can't ignore the risks."


The article references this recent piece in JAMA.

There is also this detailed Journal Sentinel article:
Medical School Leaders Cash In On Drug Company Boards

No comments:

Post a Comment